Cite
HARVARD Citation
Mohan, M. et al. (2022). Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience. American journal of hematology. 97 (7), pp. E276-E280. [Online].